| Ticker Details |
Cytokinetics, Incorporated
Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
|
| IPO Date: |
May 1, 2004 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$10.45B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 2.81%
|
| Avg Daily Range (30 D): |
$1.38 | 1.97%
|
| Avg Daily Range (90 D): |
$1.24 | 1.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.61M |
| Avg Daily Volume (30 D): |
2.44M |
| Avg Daily Volume (90 D): |
1.84M |
| Trade Size |
| Avg Trade Size (Sh.): |
101 |
| Avg Trade Size (Sh.) (30 D): |
74 |
| Avg Trade Size (Sh.) (90 D): |
65 |
| Institutional Trades |
| Total Institutional Trades: |
8,767 |
| Avg Institutional Trade: |
$3.45M |
| Avg Institutional Trade (30 D): |
$4.63M |
| Avg Institutional Trade (90 D): |
$4.62M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.7M |
| Avg Closing Trade (30 D): |
$25.32M |
| Avg Closing Trade (90 D): |
$19.68M |
| Avg Closing Volume: |
182.23K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-6.84
|
$-1.67
|
$-1.5
|
|
Diluted EPS
|
$-6.84
|
$-1.67
|
$-1.5
|
|
Revenue
|
$105.82M
|
$19.36M
|
$17.76M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-829.61M
|
$-206.03M
|
$-183.03M
|
|
Operating Income / Loss
|
$-640.25M
|
$-183.62M
|
$-178.37M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$58.9M
|
$7.32M
|
$-102.95M
|
|
PE Ratio
|
|
|
|
|
|
|
